Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Stern

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Journal of Neural Transmission|January 1, 1983
Platelet phenolsulphotransferase activity in Parkinson's diseaseV Glover, A J Lees, C Ward, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1978
Problems in the diagnosis of progressive supranuclear palsy. (Steele--Richardson--Olszewski syndrome)G D Perkin, A J Lees, G M Stern, et al.
Lancet (London, England)|February 15, 1992
Cultured human fetal and rat brain tissue and Parkinson's diseaseG M Stern, A M Walters, D J Clarke, et al.
Advances in Neurology|January 1, 1990
Premorbid personality and idiopathic Parkinson's diseaseV M Eatough, P A Kempster, G M Stern, et al.
Brain : a Journal of Neurology|June 1, 1987
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental studyD Rogers, A J Lees, E Smith, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1990
Subcutaneous apomorphine in the treatment of Parkinson's diseaseJ P Frankel, A J Lees, P A Kempster, et al.
Advances in Neurology|July 20, 1999
Neurotrophins in the pathogenesis and potential treatment of Parkinson's diseaseH F Bradford, J Zhou, B Pliego-Rivero, et al.
Clinical Neuropharmacology|December 1, 1991
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuationsA J Hughes, R Webster, M Bovingdon, et al.
Journal of Neural Transmission|January 1, 1982
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian propertiesJ D Elsworth, M Sandler, A J Lees, et al.
Neuroscience Letters|December 6, 1996
Neural toxicity of retrovirusesM J Hurley, H F Bradford, K O'Hare, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Journal of Neural Transmission|January 1, 1983
Platelet phenolsulphotransferase activity in Parkinson's diseaseV Glover, A J Lees, C Ward, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1978
Problems in the diagnosis of progressive supranuclear palsy. (Steele--Richardson--Olszewski syndrome)G D Perkin, A J Lees, G M Stern, et al.
Lancet (London, England)|February 15, 1992
Cultured human fetal and rat brain tissue and Parkinson's diseaseG M Stern, A M Walters, D J Clarke, et al.
Advances in Neurology|January 1, 1990
Premorbid personality and idiopathic Parkinson's diseaseV M Eatough, P A Kempster, G M Stern, et al.
Brain : a Journal of Neurology|June 1, 1987
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental studyD Rogers, A J Lees, E Smith, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1990
Subcutaneous apomorphine in the treatment of Parkinson's diseaseJ P Frankel, A J Lees, P A Kempster, et al.
Advances in Neurology|July 20, 1999
Neurotrophins in the pathogenesis and potential treatment of Parkinson's diseaseH F Bradford, J Zhou, B Pliego-Rivero, et al.
Clinical Neuropharmacology|December 1, 1991
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuationsA J Hughes, R Webster, M Bovingdon, et al.
Journal of Neural Transmission|January 1, 1982
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian propertiesJ D Elsworth, M Sandler, A J Lees, et al.
Neuroscience Letters|December 6, 1996
Neural toxicity of retrovirusesM J Hurley, H F Bradford, K O'Hare, et al.
Pageof 14